Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Care Frequency Assessment for Mucositis in ICU
NCT06521112Completed
- Sponsor
- Erciyes University
- Start
- May 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of chlorhexidine in mucositis (2 arms), sponsored by Erciyes University. Primary endpoints: World Health Organization Mucositis Evaluation Form at 11 days, Oral Evaluation Guide at 11 days and 1 more. Started May 2023; status: completed.
02
Drugs
chlorhexidine
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT06521112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06521112.